{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T22:52:38Z","timestamp":1778367158295,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Mucosa-associated lymphoid tissue (MALT) lymphoma, also known as extranodal marginal zone lymphoma, is more commonly detected in the stomach and rarely in the breast. Our study presented a clinical and pathological examination of a patient diagnosed with breast MALT lymphoma, supplemented with pertinent research, to offer guidance for the diagnosis and treatment of this condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>People concerns:<\/jats:title>\n            <jats:p>The occurrence of breast MALT lymphoma has risen in the past decade, but its etiology, progression and treatment response are less well-studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Breast MALT lymphoma was diagnosed by excisional biopsy and histopathology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Following breast MALT lymphoma diagnosis, the patient was transferred to the hematology department for further treatment, and she made the decision to continue observing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After 3 months of observation, the patient remained asymptomatic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Breast MALT lymphoma is an indolent disease with an asymptomatic presentation, There are no standardized treatment guidelines for breast MALT lymphoma, treatment must be tailored to the patient willingness to treat and the severity of the disease. Hence, in order to give patients a better chance of cure, more research is needed to explore its pathogenesis and more clinical trials are needed investigate the treatment of this disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037895","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:06:34Z","timestamp":1713549994000},"page":"e37895","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Breast mucosa-associated lymphoid tissue lymphoma: A case report and literature review"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8384-8109","authenticated-orcid":false,"given":"Siyi","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Breast, Jiujiang NO.1 People\u2019s Hospital, Jiujiang, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jiujiang NO.1 People\u2019s Hospital, Jiujiang, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast, Jiujiang NO.1 People\u2019s Hospital, Jiujiang, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/annonc\/mdm471","article-title":"Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International extranodal lymphoma study group.","volume":"19","author":"Ryan","year":"2008","journal-title":"Ann Oncol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/annonc\/mdp238","article-title":"Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal lymphoma study group.","volume":"20","author":"Martinelli","year":"2009","journal-title":"Ann Oncol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.","volume":"52","author":"Isaacson","year":"1983","journal-title":"Cancer"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3322\/caac.21330","article-title":"Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).","volume":"66","author":"Raderer","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.hoc.2008.07.011","article-title":"Marginal Zone Lymphomas.","volume":"22","author":"Zucca","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"v175","DOI":"10.1093\/annonc\/mdq182","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"21","author":"Zucca","year":"2010","journal-title":"Ann Oncol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-014-2042-z","article-title":"Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.","volume":"93","author":"W\u00f6hrer","year":"2014","journal-title":"Ann Hematol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00277-014-2298-3","article-title":"Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.","volume":"94","author":"Raderer","year":"2015","journal-title":"Ann Hematol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","article-title":"B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis.","volume":"24","author":"Craig","year":"2010","journal-title":"Leukemia"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/hon.2754","article-title":"Immunomodulatory treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma).","volume":"38","author":"Kiesewetter","year":"2020","journal-title":"Hematol Oncol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.semcancer.2016.07.003","article-title":"MALT lymphoma: a paradigm of NF-\u03baB dysregulation.","volume":"39","author":"Du","year":"2016","journal-title":"Semin Cancer Biol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beha.2016.09.002","article-title":"MALT lymphoma: genetic abnormalities, immunological stimulation and molecular mechanism.","volume":"30","author":"Du","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3324\/haematol.2009.005983","article-title":"Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.","volume":"94","author":"Bende","year":"2009","journal-title":"Haematologica"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","article-title":"Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.","volume":"15","author":"Smedby","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/sj.bjc.6603123","article-title":"Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin\u2019s lymphoma: a Danish population-based cohort study.","volume":"94","author":"N\u00f8rgaard","year":"2006","journal-title":"Br J Cancer"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/modpathol.2008.155","article-title":"t(11;18)(q21;q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases.","volume":"22","author":"Wang","year":"2009","journal-title":"Mod Pathol"},{"key":"R18-20250503","first-page":"7","article-title":"The bcl-2 gene in primary B cell lymphoma of mucosa-associated lymphoid tissue (MALT).","volume":"135","author":"Pan","year":"1989","journal-title":"Am J Pathol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/bjh.15953","article-title":"Transformed mucosa-associated lymphoid tissue lymphomas: a single institution retrospective study including polymerase chain reaction-based clonality analysis.","volume":"186","author":"Kiesewetter","year":"2019","journal-title":"Br J Haematol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/S0046-8177(03)00400-3","article-title":"Cytogenetic evidence for the origin of neoplastic cells in CD5-positive marginal zone B-cell lymphoma.","volume":"34","author":"Batstone","year":"2003","journal-title":"Hum Pathol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jcp.56.1.74","article-title":"Low grade marginal zone B cell lymphoma of the breast associated with localised amyloidosis and corpora amylacea in a woman with long standing primary Sj\u00f6gren\u2019s syndrome.","volume":"56","author":"Kambouchner","year":"2003","journal-title":"J Clin Pathol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00277-003-0664-7","article-title":"Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews.","volume":"82","author":"Kuper-Hommel","year":"2003","journal-title":"Ann Hematol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1200\/JCO.2004.00.8532","article-title":"Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma.","volume":"23","author":"Raderer","year":"2005","journal-title":"J Clin Oncol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2325\/jbcs.13.322","article-title":"Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions.","volume":"13","author":"Taeda","year":"2006","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.coc.0000248930.12423.2e","article-title":"Synchronous bilateral breast mucosa-associated lymphoid tissue lymphomas addressed with primary radiation therapy.","volume":"29","author":"Welsh","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3816\/CBC.2008.n.033","article-title":"Synchronous carcinoma and lymphoma of the breast.","volume":"8","author":"Anavekar","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3816\/CBC.2008.n.020","article-title":"Primary mucosa-associated lymphoid tissue lymphoma of the breast.","volume":"8","author":"Rajendran","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4081\/rt.2009.e14","article-title":"Primary breast lymphomas.","volume":"1","author":"Julen","year":"2009","journal-title":"Rare Tumors"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00404-011-2015-6","article-title":"Expect the unexpected: primary breast MALT lymphoma.","volume":"284","author":"Ghetu","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5505\/tjh.2012.26214","article-title":"Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma transformation to diffuse large B-cell lymphoma: a case report.","volume":"29","author":"Arslan","year":"2012","journal-title":"Turk J Haematol"},{"key":"R31-20250503","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12111","article-title":"EBV-positive low-grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: a report of an unusual case.","volume":"17","author":"Nassif","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1097\/RLU.0000000000000545","article-title":"18F-FDG PET\/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.","volume":"40","author":"Kim","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1831792","article-title":"Primary MALT lymphoma of the breast treated with definitive radiation.","volume":"2016","author":"Hissourou Iii","year":"2016","journal-title":"Case Rep Hematol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/tbj.12773","article-title":"Bilateral MALT lymphoma of the breast.","volume":"23","author":"Gonz\u00e1lez L\u00f3pez","year":"2017","journal-title":"Breast J"},{"key":"R35-20250503","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227581","article-title":"Breast MALT lymphoma and AL amyloidosis complicating Sj\u00f6gren\u2019s syndrome.","volume":"12","author":"Belfeki","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clml.2018.12.016","article-title":"Emerging treatment strategies for primary breast extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.","volume":"19","author":"Ludmir","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R37-20250503","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123997","article-title":"Primary breast extranodal marginal zone lymphoma in primary sj\u00f6gren syndrome: case presentation and relevant literature.","volume":"9","author":"Ingravallo","year":"2020","journal-title":"J Clin Med"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.radcr.2022.07.105","article-title":"A rare case of synchronous mucosa-associated lymphoid tissue (MALT) lymphoma involving bilateral breasts and subcutaneous tissues.","volume":"17","author":"Anendaga","year":"2022","journal-title":"Radiol Case Rep"},{"key":"R39-20250503","first-page":"e34286","article-title":"A rare case of breast mucosa-associated lymphoid tissue (MALT) lymphoma with amyloid deposition in a patient with sjogren\u2019s syndrome.","volume":"15","author":"Dalal","year":"2023","journal-title":"Cureus"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sj\u00f6gren syndrome.","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of helicobacter pylori eradication on early stage gastric mucosa\u2013associated lymphoid tissue lymphoma.","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up.","volume":"117","author":"Ruskon\u00e9-Fourmestraux","year":"2015","journal-title":"Radiother Oncol"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2008.12.004","article-title":"Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma.","volume":"90","author":"Tomita","year":"2009","journal-title":"Radiother Oncol"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","article-title":"Clinical activity of rituximab in gastric marginal zone non-hodgkin\u2019s lymphoma resistant to or not eligible for anti-helicobacter pylori therapy.","volume":"23","author":"Martinelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with Rituximab plus chlorambucil versus either Chlorambucil or Rituximab monotherapy.","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet (London, England)"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1182\/blood-2013-11-531327","article-title":"Randomized trial of bendamustine-rituximab or R-CHOP\/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.","volume":"123","author":"Flinn","year":"2014","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:10:22Z","timestamp":1746317422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":47,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037895","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}